257 related articles for article (PubMed ID: 25568177)
21. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
22. Myeloid-derived suppressor cells protect mouse models from autoimmune arthritis via controlling inflammatory response.
Zhang L; Zhang Z; Zhang H; Wu M; Wang Y
Inflammation; 2014 Jun; 37(3):670-7. PubMed ID: 24264477
[TBL] [Abstract][Full Text] [Related]
23. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
24. Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study.
Chen H; Qin S; Lei A; Li X; Gao Q; Dong J; Xiao Q; Zhou J
Int Immunopharmacol; 2017 Jun; 47():150-158. PubMed ID: 28407569
[TBL] [Abstract][Full Text] [Related]
25. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
[TBL] [Abstract][Full Text] [Related]
26. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
[TBL] [Abstract][Full Text] [Related]
27. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.
Görgün GT; Whitehill G; Anderson JL; Hideshima T; Maguire C; Laubach J; Raje N; Munshi NC; Richardson PG; Anderson KC
Blood; 2013 Apr; 121(15):2975-87. PubMed ID: 23321256
[TBL] [Abstract][Full Text] [Related]
28. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
[TBL] [Abstract][Full Text] [Related]
29. Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice.
Singh UP; Singh NP; Singh B; Hofseth LJ; Taub DD; Price RL; Nagarkatti M; Nagarkatti PS
Brain Behav Immun; 2012 Jan; 26(1):72-82. PubMed ID: 21807089
[TBL] [Abstract][Full Text] [Related]
30. SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis.
Zhu K; Zhang N; Guo N; Yang J; Wang J; Yang C; Yang C; Zhu L; Xu C; Deng Q; Zhu R; Wang H; Chen X; Shi Y; Li Y; Leng Q
Int J Biochem Cell Biol; 2014 Sep; 54():89-97. PubMed ID: 25035167
[TBL] [Abstract][Full Text] [Related]
31. Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
Kapanadze T; Medina-Echeverz J; Gamrekelashvili J; Weiss JM; Wiltrout RH; Kapoor V; Hawk N; Terabe M; Berzofsky JA; Manns MP; Wang E; Marincola FM; Korangy F; Greten TF
Eur J Immunol; 2015 Apr; 45(4):1148-58. PubMed ID: 25616156
[TBL] [Abstract][Full Text] [Related]
32. A copper chelate selectively triggers apoptosis in myeloid-derived suppressor cells in a drug-resistant tumor model and enhances antitumor immune response.
Chakraborty P; Das S; Banerjee K; Sinha A; Roy S; Chatterjee M; Choudhuri SK
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):165-75. PubMed ID: 24611750
[TBL] [Abstract][Full Text] [Related]
33. Endogenous glucocorticoids promote the expansion of myeloid-derived suppressor cells in a murine model of trauma.
Zhang K; Bai X; Li R; Xiao Z; Chen J; Yang F; Li Z
Int J Mol Med; 2012 Aug; 30(2):277-82. PubMed ID: 22664747
[TBL] [Abstract][Full Text] [Related]
34. Increased, but Functionally Impaired, CD14(+) HLA-DR(-/low) Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells.
Soler DC; Young AB; Fiessinger L; Galimberti F; Debanne S; Groft S; McCormick TS; Cooper KD
J Invest Dermatol; 2016 Apr; 136(4):798-808. PubMed ID: 26807516
[TBL] [Abstract][Full Text] [Related]
35. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
36. The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis.
Guan Q; Moreno S; Qing G; Weiss CR; Lu L; Bernstein CN; Warrington RJ; Ma Y; Peng Z
J Leukoc Biol; 2013 Oct; 94(4):803-11. PubMed ID: 23901119
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells.
Varga G; Ehrchen J; Tsianakas A; Tenbrock K; Rattenholl A; Seeliger S; Mack M; Roth J; Sunderkoetter C
J Leukoc Biol; 2008 Sep; 84(3):644-50. PubMed ID: 18611985
[TBL] [Abstract][Full Text] [Related]
40. Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function.
Landoni VI; Martire-Greco D; Rodriguez-Rodrigues N; Chiarella P; Schierloh P; Isturiz MA; Fernández GC
Clin Sci (Lond); 2016 Feb; 130(4):259-71. PubMed ID: 26582821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
